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Abstract
Cadmium (Cd) is a ubiquitous environmental contaminant, a known carcinogen, and understudied as a developmental
toxicant. In the present study, we examined the relationships between Cd levels during pregnancy and infant birth
outcomes in a prospective pregnancy cohort in Durham, North Carolina. The study participants (n = 1027) had a mean Cd
level of 0.46 mg/L with a range of ,0.08 to 2.52 mg/L. Multivariable models were used to establish relationships between
blood Cd tertiles and fetal growth parameters, namely birth weight, low birth weight, birth weight percentile by gestational
age, small for gestational age, pre-term birth, length, and head circumference. In multivariable models, high maternal blood
Cd levels ($0.50 mg/L) during pregnancy were inversely associated with birth weight percentile by gestational age
(p = 0.007) and associated with increased odds of infants being born small for gestational age (p,0.001). These observed
effects were independent of cotinine-defined smoking status. The results from this study provide further evidence of health
risks associated with early life exposure to Cd among a large pregnancy cohort.
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Introduction
Cadmium (Cd) is a heavy metal ubiquitous in the environment
and understudied as a developmental toxicant. In animal models,
Cd is embryotoxic and teratogenic [1]. In humans, Cd is a known
lung carcinogen and exposure has been linked to adverse effects on
the liver, kidney, bladder, stomach and pancreas [2,3,4].
Furthermore, there is growing evidence of associations between
Cd and adverse birth outcomes, such as small for gestational age
and preterm birth [5,6,7,8,9,10]. In addition to its impact on
growth parameters, Cd is an established epigenetic modifier [11],
thus there is the potential that prenatal exposure to Cd may also
have long-term implications on child development.
The largest source of Cd exposure is through tobacco products.
An average cigarette contains 1–2 mg of Cd, of which smokers
absorb a portion via inhalation [12]. One cigarette has been
shown to increase the blood Cd level by approximately 0.1–
0.2 mg/L [13]. In the context of smoking, cotinine, the primary
metabolite of nicotine and a biomarker of cigarette smoke
exposure, has a half-life of less than one day [14,15]. Thus,
cotinine is a general measure of recent cigarette exposure. While
tobacco products are the largest source of exposure, diet is the
most common exposure source. Cd can be found at elevated levels
in food such as shellfish, organ meats, cereals, root vegetables, and
green leafy vegetables [16,17]. It is estimated that the average Cd
intake from food varies between 8 and 25 mg per day [4]. Cd
exposure may also occur via house dust and consumer products, as
well as due to proximity to industrial sources [4,18,19,20]. The
half-life of Cd in blood can range up to 10 years and thus may also
serve as a good reflection of historical exposures [4,13].
Limited information is available on Cd levels among pregnant
women in the United States. A recent study among approximately
200 pregnant women in central North Carolina found Cd blood
levels ranging up to 2.79 mg/L with a geometric mean of 0.18 mg/
L [21]. Furthermore, average Cd blood levels among a pregnant
women subsample of the 2003–2004 National Health and
Nutrition Examination Survey (NHANES) were similar with a
mean of 0.22 mg/L (n = 253) compared to 0.33 mg/L (n = 1396)
among non-pregnant women of childbearing age [22].
In this paper, we assess the relationship between Cd levels
among pregnant women and birth outcomes. While smoking is
well-established as a cause of adverse birth outcomes as well as a
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source of Cd in blood, we hypothesized that Cd has detrimental
effects on fetal health independent of smoking. As both Cd and
cotinine were assessed, we were able to examine the relationship of
Cd independently on measured birth outcomes.
Materials and Methods
Study population
The Healthy Pregnancy, Healthy Baby Study is a prospective
cohort study that enrolled pregnant women living in Durham
County, North Carolina, U.S., from 2005 to 2010. The study, part
of the Southern Center on Environmentally Driven Disparities in
Birth Outcomes (SCEDDBO), aims to examine the effects of
environmental, social, and host factors on racial disparities in
pregnancy outcomes. Women receiving prenatal care at either the
Duke University Obstetrics Clinic or the Durham County Public
Health’s Prenatal Clinic were eligible to participate if they were
between 18 and 28 weeks of gestation, were at least 18 years of
age, were English-literate, lived in Durham County, did not have a
multi-fetal gestation or any known congenital anomalies, and
planned to deliver at Duke University Medical Center (DUMC).
Of the 2,306 women approached to participate in the study, 1,897
(82.3%) women enrolled. Women were excluded if they were less
than 18 years old, non-English literate, lived outside of Durham
County, were less than 18 or greater than 28 weeks of gestation at
the time of enrollment, had a multi-fetal gestation, had a known
fetal genetic or congenital anomaly, or were not planning to
deliver at DUMC. Study participants gave written documentation
of consent for participation. This study was reviewed and
approved by the Duke University Institutional Review Board
(Pro00007633).
Previously, this cohort was used to examine lead and mercury
exposures among pregnant women [23,24]. Because the subset of
women for whom lead, mercury, and Cd exposure measurements
are available varies, we cannot directly connect Cd exposure levels
from this study to the exact same populations in the previous
studies.
Blood Cd and cotinine levels
Maternal blood samples were collected at the time of delivery in
a Monoject trace element blood collection tube containing the
anticoagulant EDTA. Whole blood samples were analyzed by
Inductively Coupled Plasma-Mass Spectrometry at the Mayo
Clinical Laboratories (MCL) or the Dwyer (Duke) labs for Cd.
Plasma samples were analyzed at the MCL or University of
California, San Francisco (UCSF) Clinical Pharmacology Labo-
ratory for cotinine. The limits of detection (LOD) for Cd were 0.2
and 0.08 mg/L at the MCL and Duke Laboratories, respectively,
with 29.9% below the LOD at the MCL and 3.5% below the
LOD at Duke Laboratories. The LOD for cotinine at the MCL
was 2.0 mg/L with 75.4% below the LOD and was 0.02 ug/L with
16.4% below the LOD at UCSF. Because women vary in timing
of delivery, blood samples were collected from 23–42 weeks of
gestation, with a median gestational age of 39 weeks (interquartile
range: 37–39 weeks).
Since the labs that analyzed the samples for both Cd and
cotinine levels changed over the course of the study, the results
were normalized across labs and values below the detection limits
were imputed using the rank permutation method proposed by
Burgette and Reiter [25]. Blood cotinine levels above 10 mg/L are
indicative of active smoking [26,27]. This cutoff was used to define
participants as smokers or non-smokers. For the purposes of this
study, blood Cd levels were classified as low (#0.28 mg/L),
medium (0.29–0.49 mg/L) or high ($0.50 mg/l) based on tertiles.
Birth outcomes
Birth outcome information, including birth weight, newborn
length, gestational age and head circumference, were obtained
through the infant’s electronic medical record. Births were
dichotomized into low birth weight (LBW; ,2500 g) and pre-
term birth (PTB; ,37 weeks gestational age). Birth weight
percentile was calculated based upon national normalized birth
weight for gestational age and sex, and dichotomized based on
small for gestational age (SGA) defined at ,10th percentile. Both
continuous and binary outcome measures were used for analysis
because most increases in birth weight are associated with better
infant health and development outcomes [28,29].
Sociodemographic and patient characteristics
Demographic, health behavior, and medical history data were
obtained by direct patient interview and through electronic
medical record review at the time of enrollment. Age was
trichotomized as ,20 years, 20–34 years, and $35 years.
Educational attainment was classified as no high school degree,
completed high school, and schooling beyond high school. We
dichotomized patient insurance status as having private insurance
or not having private insurance (i.e., participants who were either
uninsured or covered by Medicaid or other public health
insurance). Lack of private insurance was considered a proxy for
lower socioeconomic status (SES) [30].
Data restrictions
The full study cohort (n = 1,852) was restricted to non-Hispanic
black and non-Hispanic white participants with an imputed blood
Cd level per the transformation described above, leaving 1438
eligible women. An additional 408 participants were excluded due
to missing blood cotinine levels, and three participants with
missing covariate data were excluded. After these exclusions the
study sample size was n = 1027. The sample size varies in some
analyses due to missingness in birth outcome data.
Statistical analysis
Exploratory analyses were conducted to describe blood Cd levels
by patient characteristics. Cohen’s k was used to assess agreement
between reported and blood-cotinine-defined smoking status.
Unadjusted relationships between birth outcomes and patient
characteristics were explored using chi-square and nonparametric
one-way tests. For binary outcomes (e.g. SGA) we characterized
associations using chi-square tests and odds ratios, and for
continuous outcomes (e.g. birth weight), we used two-sample t-tests
and analysis of variance (ANOVA) with Tukey-Kramer corrections
for multiple comparisons. A Satterthwaite approximation was used
for the degrees of freedom for comparisons in which group
variances were heterogeneous; with a test statistic denoted as ts.
In order to assess the relationship between Cd and birth
outcomes, linear regression models were fit for continuous
measures of birth outcomes and logistic regression models for
dichotomous outcomes, controlling for race, age, education,
insurance status, parity, history of anxiety, cotinine defined
smoking status, and infant sex. Since blood cotinine levels may
covary with Cd, models were fit with and without an interaction
term between the two exposures. All analyses were conducted
using SAS 9.3 (SAS Institute, Cary, NC).
Results
Characteristics of the study population
The demographic composition of the study population is
presented in Table 1. Of the 1,027 participants meeting all
Maternal Cadmium Exposure and Birth Outcomes
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restrictions, the majority was non-Hispanic Black (74.2%), had
previously given birth (74.9%) and lacked private insurance
(71.1%). Roughly 87% had a minimum of a high school
education. On average, the participants were 26 years old,
ranging from 18–40 years old. Nine percent of the participants
had a history of anxiety.
Self-reported smoking combined with medical record data
identified 169 (16.4%) participants as current or past smokers.
Based on blood cotinine levels exceeding 10 mg/L, 24.8% of
participants were classified as active smokers during pregnancy.
Agreement between the two measures of smoking status was
substantial (k= 0.639, p,.0001), and all subsequent analyses
presented here use cotinine-defined smoking status.
Cd levels in the study population
The mean blood Cd level was 0.46 mg/L (SD 0.34 mg/L), and
the 50th percentile was 0.40 mg/L with an inter-quartile range of
0.33 mg/L. Over 60% of the study population had a blood Cd
level above the mean for US adults (0.32 mg/L), and 77.7% had a
blood Cd level greater than the mean for pregnant women
(0.22 mg/L) [31]. This indicates that this Durham County study
population had higher levels of Cd exposure than expected given
national data. Since blood Cd levels in our study population do
not reflect national levels, blood Cd levels were classified based on
tertiles. In all subsequent analyses blood Cd levels are referred to
as low (#0.28 mg/L), medium (0.29–0.49 mg/L), or high ($
0.50 mg/l).
Chi-square tests showed differences in blood Cd levels based on
education, insurance status, parity, and cotinine-defined smoking
status (see Table 1). No differences were observed by age, race,
relationship status, history of anxiety, parity, or infant sex.
Compared to non-smokers, smokers had 2.34 (95% CI: 1.50,
3.74) increased odds of having a medium blood Cd level and 3.87
(95% CI: 2.79, 5.49) increased odds of having a high blood Cd
Table 1. Study population characteristics.
N (Column)
All (Column %)





(n = 330) p*
(n = 1027)
Age (years) 0.1242
,20 137 (13) 54 (16) 50 (14) 33 (10)
20–34 748 (73) 250 (73) 254 (72) 244 (74)
$35 142 (14) 39 (11) 50 (14) 53 (16)
Race 0.0518
non-Hispanic white 266 (26) 103 (30) 91 (26) 72 (22)
non-Hispanic black 761 (74) 240 (70) 263 (74) 258 (78)
Education Level ,0.0001
,High school 135 (13) 35 (10) 35 (10) 65 (20)
High school 360 (35) 113 (33) 122 (35) 125 (38)
. High school 532 (52) 195 (57) 197 (56) 140 (42)
Relationship status 0.2325
Committed rel. 760 (74) 259 (76) 268 (76) 233 (71)
No committed rel. 267 (26) 84 (24) 86 (24) 97 (29)
Insurance status 0.0003
Private insurance 290 (28) 118 (34) 104 (29) 68 (21)
No private insurance 737 (72) 225 (66) 250 (71) 262 (79)
History of anxiety 0.6558
No 928 (90) 308 (90) 324 (92) 29 (90)
Yes 99 (10) 35 (10) 30 (8) 34 (10)
Parity status 0.0067
Pluriparous 771 (75) 237 (69) 274 (77) 260 (79)
Nulliparous 256 (25) 106 (31) 80 (23) 70 (21)
Infant’s sex 0.1417
Male 512 (50) 167 (49) 191 (54) 154 (47)
Female 515 (50) 176 (51) 163 (46) 176 (53)
Blood cotinine ,0.0001
# 10 mg/L 771 (75) 312 (91) 287 (81) 172 (52)
. 10 mg/L 256 (25) 31 (9) 67 (19) 156 (48)
Note: Percentages are reported as column-wise. Blood cadmium levels: low – #0.28 mg/L, medium – 0.29–0.49 mg/L, high – $0.50 mg/l.
* p-values represent results from chi-square tests.
doi:10.1371/journal.pone.0109661.t001
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level compared to a low blood Cd level. Smokers (versus
nonsmokers) had a 9.06 (95% CI: 5.98, 14.13) increased odds of
having a high versus medium blood Cd level.
Unadjusted association between birth outcomes and Cd
Birth outcomes are summarized by study population demo-
graphics and blood Cd levels in Table 2. The average weight of
the newborns was 3095 g (SD 651 g) and ranged from 500 g to
5160 g. Birth weight was lower among infants whose mothers were
non-Hispanic black (p,.0001), without private insurance (p,
.0001), with elevated blood cotinine levels (p = 0.0007), and with
high blood Cd levels (p = 0.0203; High – Low, p = 0.0148).
Additionally, male infants weighed more than females (p = 0.0012),
which is consistent with national data.
Of the infants, 148 (14.41%) were considered low birth weight
(LBW). Women under 20 years had 1.65 (95% CI: 1.03, 2.62)
times the odds of having a LBW child compared to women 20–34
years, but there was no statistical difference between women ,20
and $35 years or 20–34 and $35 years. LBW was 3.05 (95% CI:
1.80, 5.15) times more frequent among non-Hispanic blacks than
non-Hispanic whites. Women without private insurance were 2.12
(95% CI: 1.35, 3.34) times as likely to have LBW as women with
private insurance. Elevated levels of cotinine during pregnancy
corresponded to 1.67 (95% CI: 1.15, 2.42) times the odds of a
LBW infant compared to blood cotinine levels below 10 mg/l.
There was no relationship between increased odds of LBW and
Cd levels.
Gestational age at delivery ranged from 23 weeks to 42 weeks
with a mean of 38.1 weeks (SD 2.5 weeks). Gestational periods
were slightly shorter among non-Hispanic blacks (p = 0.045) and
nulliparous women (p = 0.0080). In unadjusted models, gestational
age at delivery did not vary by blood cotinine or blood Cd levels.
Birth weight percentile for gestational age and sex ranged from
the 0th to 99.5th percentiles with the average at the 39.30th
percentile (SD 27.59 percentiles). There were significant relation-
ships between birth weight percentile and mother’s age
(p = 0.0159), race (p,.0001), education (p = 0.0025), relationship
status (p = 0.0227), insurance status (p,.0001), cotinine-defined
smoking status (p,.0001), and blood Cd levels (p,.0001). High
blood Cd levels were associated with significantly lower age- and
sex-adjusted birth weight percentiles compared to medium blood
Cd levels (p = .0025) and low blood Cd levels (p,.0001). There
was not a significant difference between women with medium and
low blood Cd levels.
There were 154 (15%) infants born small for gestational age
(SGA). Relative to women at least 35 years old, SGA births were
2.78 (95% CI: 1.35, 5.73) times more frequent among women
younger than 20, and 1.95 (95% CI: 1.04, 3.64) times more
frequent among women 20–34 years. Non-Hispanic black women
were 4.86 (95% CI: 2.65, 8.91) times as likely as non-Hispanic
white women to give birth to an SGA infant. Women without
private health insurance were 2.66 (95% CI: 1.66, 4.27) more
likely to have an SGA infant compared to women with private
health insurance. Elevated blood cotinine levels corresponded to
1.92 (95% CI: 1.34, 2.77) times the odds of SGA. High blood Cd
levels corresponded to 1.98 (95% CI: 1.30, 3.02) times the odds of
SGA compared to low blood Cd levels, and 1.95 (95% CI: 1.29,
2.95) times the odds of SGA compared to medium blood Cd levels.
In addition, the study cohort includes 153 infants (15%) who
were born pre-term (PTB). Relative to women 20–34 years, PTB
infants were 1.66 (95% CI: 1.05, 2.61) times more frequent among
women at least 35 years old. There was no difference in odds of
PTB based on maternal cotinine or Cd levels.
Mean head circumference was 33.40 cm (SD 2.52 cm) ranging
from 15–49.5 cm among the infants. Head circumference was
lower among infants whose mothers were non-Hispanic black (p,
.0001), without private insurance (p,.0001), and among cotinine-
defined smokers (p = 0.0265). Newborn length ranged from 19.5–
58.0 cm with an average of 48.27 (SD 3.57 cm). Infant newborn
length was lower for women who were non-Hispanic black (p,
.0001), without private insurance (p,.0001), and cotinine-defined
smokers (p = 0.0009). Neither head circumference nor length was
associated with blood Cd levels.
Adjusted association between birth outcomes and Cd
Multivariable regression was used to further examine these
relationships while adjusting for confounders including maternal
age, education, and pregnancy history. Consistent with the
unadjusted analysis, Cd levels were not associated with preterm
birth, head circumference, or length (Tables 3 and 4). However
significant associations between Cd levels and birth weight
percentile by gestational age and SGA were identified (Tables 3
and 4).
Controlling for smoking status and other demographic vari-
ables, on average, pregnant women in the high Cd exposure group
were found to have infants 6.1 birth weight for gestational age
percentile points lower (95% CI: 210.5 to 21.8) than the low Cd
exposure group (p = 0.0057) and were 1.71 (95% CI: 1.10, 2.64)
times as likely to be SGA. While the medium Cd exposure tertile
was not statistically significantly different from the low exposure
group, a negative monotonic relationship was observed between
Cd exposure group and birth weight percentile. Smoking was also
significantly associated with lower birth weight percentile by
gestational age with a similar magnitude as high Cd exposure (2
5.2; 95% CI: 29.5 to 20.9; p = 0.0179). Race exhibited the largest
effect on birth weight percentile, with non-Hispanic black women,
on average, having an infant 11.2 birth weight for gestational age
percentile points lower (CI: 215.7 to 26.7) than non-Hispanic
white women. Non-Hispanic black women were also 4.42 (95%
CI: 2.34, 8.35) times more likely to have an SGA infant. Pregnant
women without private health insurance, as well as nulliparous
women, had, on average, lower birth weight infants. No
differences were observed by age or educational status.
Discussion
Low birth weight is an important public health problem
globally, associated with neonatal mortality and morbidity, as well
as increased disease risk later in life [32]. This study contributes to
the growing evidence on the relationship between maternal
exposure to Cd during pregnancy and adverse pregnancy
outcomes [7,10,33]. Among this large urban and minority cohort
of women pregnant women, over 60% have blood Cd levels that
exceed the median for US adults as reported in NHANES [31].
These levels are likely a result of a combination of exposure
sources, including but not limited to cigarette smoke. While 25%
of the pregnant women were active smokers based on blood
cotinine levels, elevated blood Cd levels were still observed in the
non-smokers ranging from ,0.08–2.26 mg/L. In this study, which
evaluated the association between Cd and birth outcomes, we
observed an inverse relationship between Cd exposure and birth
weight (as a percentile and as SGA). Specifically, we show that
infants born to women with blood Cd in the highest tertile of
exposure ($0.50 mg/L) were born on average 6 birth weight for
gestational age percentile points lower compared to the lowest Cd
exposed group. In addition, infants born to women in the highest
Maternal Cadmium Exposure and Birth Outcomes
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Cd exposure tertile were 1.71 times as likely to be born small for
gestational age.
There are various possible mechanisms by which Cd exposure
during pregnancy can limit fetal growth. Importantly, prior
investigations have demonstrated that while Cd accumulates in
the human placenta, the placenta is not a complete barrier [34].
As a result, concentrations of Cd in cord blood representing fetal
levels increase with maternal exposure [5,35]. In addition, Cd
levels in cord blood and in the placenta are strongly correlated
with maternal blood levels [5,36]. Infant birth weight may be
negatively influenced by Cd levels as a result of the indirect toxic
effects of the metal on the placenta or direct effects on the fetus. It
is hypothesized that the higher Cd levels can lead to insufficient
transfer of zinc to the fetus, which can retard intrauterine growth
[35,37,38]. Another possible mechanism is through the endocrine
Table 3. Adjusted estimates and standard errors for continuous birth outcomes.
Beta (SE)
Birth weight Gest. age
Birth weight percentile for
gestational age (n = 1027) Head circ. Length
(n = 1027) (n = 1027) (n = 992) (n = 994)
Blood Cd: High 279.7 (52.8) 0.09 (0.21) 26.11 (2.21)** 20.13 (0.21) 20.04 (0.30)
Blood Cd: Medium 263.0 (48.3) 20.29 (0.19) 21.23 (2.02) 20.02 (0.19) 20.33 (0.27)
Blood cotinine. 10 mg/L 298.1 (52.3) 20.08 (0.21) 25.18 (2.19)* 20.18 (0.21) 20.63 (0.30)*
Age ,20 years 20.08 (62.8) 0.27 (0.25) 20.75 (2.63) 0.38 (0.25) 0.31 (0.35)
Age $34 years 246.0 (61.9) 20.29 (0.25) 0.01 (2.59) 0.02 (0.25) 20.45 (0.35)
Race: NHB 2293.2 (54.7)*** 20.67 (00.22)** 211.30 (2.29)*** 21.07 (0.22)*** 21.51 (0.31)***
Education: ,HS 77.8 (65.0) 20.08 (0.26) 4.43 (2.72) 0.13 (0.26) 0.13 (0.36)
Education:. HS 230.4 (48.5) 20.18 (0.19) 0.36 (2.03) 20.08 (0.19) 20.08 (0.27)
No private insurance 281.1 (57.8) 0.05 (0.23) 25.92 (2.42)* 20.36 (0.23) 20.38 (0.32)
Parity status: Nulliparous 63.9 (48.0) 20.33 (0.19) 25.72 (2.01)** 0.27 (0.19) 0.14 (0.27)
Infant’s sex: Female 2113.5 (39.5)** 0.19 (0.16) - 20.34 (0.16)* 20.5 (0.22)*
History of anxiety: Yes 2187.8 (68.5)** 20.48 (0.27) 27.58 (2.87)** 20.46 (0.27) 20.78 (0.38)*
Intercept 3481.3 (78.0)*** 38.9 (0.31)*** 57.92 (3.04)*** 34.52 (0.31)*** 50.20 (0.44)***
Note: estimates are adjusted for the other model covariates; infant’s sex was excluded as a covariate from the birth weight percentile for gestational age model since
the birth weight percentiles are sex-adjusted. Blood cadmium levels: low – #0.28 mg/L, medium – 0.29–0.49 mg/L, high – $0.50 mg/l.
* p,0.05, ** p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0109661.t003
Table 4. Adjusted odds ratios and 95% confidence intervals for dichotomous birth outcomes.
Odds ratio (95% confidence interval)
LBW SGA PTB
(n = 1027) (n = 1027) (n = 1027)
Blood Cd: High 1.07 (0.67, 1.73) 1.72 (1.1, 2.68)* 1.17 (0.74, 1.87)
Blood Cd: Medium 1.13 (0.73, 1.76) 0.99 (0.63, 1.55) 1.24 (0.81, 1.89)
Blood cotinine. 10 mg/L 1.49 (0.96, 2.29) 1.41 (0.94, 2.12) 0.90 (0.57, 1.42)
Age ,20 years 1.55 (0.93, 2.56) 1.25 (0.76, 2.04) 1.08 (0.62, 1.88)
Age $34 years 1.39 (0.79, 2.46) 0.73 (0.39, 1.39) 1.72 (1.06, 2.82)*
Race: NHB 2.89 (1.59, 5.26)*** 4.38 (2.3, 8.35)*** 1.96 (1.18, 3.28)*
Education: ,HS 1.06 (0.61, 1.82) 1.12 (0.67, 1.86) 1.01 (0.56, 1.81)
Education:. HS 1.25 (0.82, 1.91) 1.20 (0.8, 1.79) 1.37 (0.9, 2.08)
No private insurance 1.32 (0.76, 2.30) 1.22 (0.71, 2.09) 1.03 (0.63, 1.68)
Parity status: Nulliparous 0.98 (0.64, 1.52) 0.72 (0.48, 1.08) 1.23 (0.80, 1.90)
Infant’s sex: Female 1.31 (0.92, 1.87) 1.50 (1.07, 2.12)* 0.85 (0.6, 1.20)
History of anxiety: Yes 1.56 (0.87, 2.80) 1.67 (0.94, 2.97) 1.43 (0.81, 2.50)
Note: estimates are adjusted for the other model covariates; LBW – low birth weight, SGA – small for gestational age, PTB – preterm birth; Blood cadmium levels: low –
#0.28 mg/L, medium – 0.29–0.49 mg/L, high – $0.50 mg/l.
* p,0.05, ***p,0.001.
doi:10.1371/journal.pone.0109661.t004
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disrupting properties of Cd which may reduce in utero gene and
subsequently protein expression linked to fetal growth [39].
While we observe a relationship between Cd exposure
independent of smoking and lower birth weight percentile and
SGA among pregnant women in NC, this study is not without
limitations. The study population comes from pregnant women in
one urban county in North Carolina that intentionally over-
sampled for non-Hispanic black women and may not be
representative of Cd levels among pregnant women in other
areas. This study used maternal blood levels as a proxy for
exposure to the fetus via cord blood or the placenta. While
maternal blood Cd levels are strongly correlated with Cd in cord
blood and in the placenta, direct measures of infant Cd levels
would provide a more direct measure of the association between
fetal Cd exposure and birth outcomes. Additionally, the labora-
tories used to analyze samples for both Cd and cotinine levels
changed over the course of the study. Although we addressed the
change in labs using a rank permutation method to transform
values to the same scale, the normalized values may differ from the
true scale; therefore we can only make inferences about relative
Cd exposure. Data were not available on dietary information or
ambient Cd concentration, two important sources of Cd exposure,
particularly among the non-smoking cohort. Regardless of
knowing exposure sources, this study provides evidence that
maternal blood Cd is associated with adverse birth outcomes.
Future research is needed to identify the direct sources of exposure
among non-smokers in order to design appropriate inventions and
improve public health.
Conclusions
We observed a significant negative association between mater-
nal Cd exposure and birth weight. This study suggests that Cd
impairs fetal growth, independent of the contribution of smoking.
These findings add to the growing body of literature supporting
the negative effects of fetal Cd exposure on birth outcomes.
Additionally, they highlight the presence of elevated levels of Cd in
pregnant women in NC, and highlight the need for understanding
the role of dietary, occupational, environmental, lifestyle and host
factors that influence Cd exposure levels. Such information is
important for the development of successful invention programs
aimed at reducing exposures and narrowing disparities in birth
outcomes.
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